A Kierkegaard Anthology Quiz | Eight Week Quiz G

Robert W. Bretall
This set of Lesson Plans consists of approximately 105 pages of tests, essay questions, lessons, and other teaching materials.

A Kierkegaard Anthology Quiz | Eight Week Quiz G

Robert W. Bretall
This set of Lesson Plans consists of approximately 105 pages of tests, essay questions, lessons, and other teaching materials.
Buy the A Kierkegaard Anthology Lesson Plans
Name: _________________________ Period: ___________________

This quiz consists of 5 multiple choice and 5 short answer questions through Chapter 17, The Attack Upon Christendom.

Multiple Choice Questions

1. What does the pseudonymous author of The Fragments resist?
(a) Love.
(b) Discovering himself.
(c) Discipleship of Jesus.
(d) Going to church.

2. In Chapter 13, what does Robert Bretall argue 1848 is for Kierkegaard's writing?
(a) The year of his first commercial success.
(b) The year he starts doubting Christ.
(c) The height of his productivity.
(d) The year he realizes he still loves Regina.

3. What does The Sickness Unto Death argue is contained within man?
(a) Christ.
(b) The self.
(c) The infinite and the finite.
(d) Faith.

4. What does the first letter in Either/Or analyze?
(a) Death.
(b) Romantic love.
(c) Christ.
(d) God's influence on mankind.

5. What does Kierkegaard argue men always appear to be biased by?
(a) Their education.
(b) His own perspective.
(c) Their environment.
(d) Christ.

Short Answer Questions

1. When were the last of Kierkegaard aesthetic writings published according to Robert Bretall in Chapter 7?

2. What does Kierkegaard argue the present is ruled by?

3. What does Kierkegaard's work focus on?

4. Where in Either/Or are the edifying discourses published?

5. What does Robert Bretall in Chapter 11 say Kierkegaard rejects and critiques?

(see the answer key)

This section contains 207 words
(approx. 1 page at 300 words per page)
Buy the A Kierkegaard Anthology Lesson Plans
Copyrights
BookRags
A Kierkegaard Anthology from BookRags. (c)2026 BookRags, Inc. All rights reserved.